rs7753394 — TNFAIP3

The 6q23 Regulatory Switch — A Tag SNP in the TNFAIP3 Neighborhood

A key principle in genomics is that most disease-associated variants found by genome-wide association studies are not located in protein-coding sequences — they sit in the regulatory landscape between genes, tuning how much of a critical protein gets made. rs7753394 resides on chromosome 6 in the intergenic stretch between OLIG3¹¹ OLIG3
Oligodendrocyte lineage transcription factor 3 — a transcription factor with roles in neural development; not itself directly implicated in autoimmune disease and TNFAIP3²² TNFAIP3
Tumor necrosis factor alpha-induced protein 3 — the gene encoding A20, the immune system's master brake on NF-kB inflammatory signaling, approximately 100 kb upstream of the TNFAIP3 transcription start site. It was captured in the landmark 2007 Wellcome Trust Case Control Consortium GWAS³³ Wellcome Trust Case Control Consortium GWAS
The WTCCC enrolled 14,000 cases across 7 common diseases (bipolar disorder, coronary artery disease, Crohn's disease, rheumatoid arthritis, type 1 and 2 diabetes, and hypertension) and 3,000 shared controls in the largest genetic association study of its time and has since been typed in studies of ulcerative colitis, Crohn's disease, and inflammatory pathway genetics.

The Mechanism

rs7753394 is a tag SNP⁴⁴ tag SNP
A tag SNP is a variant in high linkage disequilibrium with nearby variants; it "tags" the same haplotype block and serves as a proxy for the causal variant in that chromosomal region in the 6q23 regulatory zone.

A20, encoded by TNFAIP3, is a dual-function ubiquitin-editing enzyme⁵⁵ dual-function ubiquitin-editing enzyme
A20 has two catalytic domains: an N-terminal OTU deubiquitinase that removes activating K63-linked ubiquitin chains from TRAF6, NEMO, and RIP1; and a C-terminal ZnF4 domain that adds inhibitory K48-linked ubiquitin chains targeting these signaling proteins for proteasomal degradation that terminates NF-kB inflammatory signaling once an immune response has served its purpose. Without sufficient A20, the inflammatory cascade persists beyond its useful window — sustaining cytokine production, prolonging immune cell activation, and raising the probability that the immune system loses self-tolerance.

The 6q23 locus contains three statistically independent association signals for rheumatoid arthritis — rs6920220 (the primary risk signal), rs13207033 (a protective signal), and rs5029937 (an additional risk signal within TNFAIP3 intron 2).

The Evidence

rs7753394 was included in the WTCCC 2007 study⁶⁶ WTCCC 2007 study
A landmark genome-wide association study enrolling 14,000 cases across 7 common diseases including Crohn's disease, rheumatoid arthritis, and type 1 diabetes, which established the 6q23 intergenic region as a genuine autoimmune susceptibility locus. The subsequent Fisher et al. 2008 study⁷⁷ Fisher et al. 2008 study
Nature Genetics study identifying ulcerative colitis loci including ECM1 and five shared with Crohn's disease specifically tested rs7753394 in the 6q23 region as part of a cross-disease replication panel — UC testing did not find significant association (p = 0.61), indicating the 6q23 signal for UC does not extend to this specific tag SNP.

The Eleftherohorinou 2009 pathway analysis⁸⁸ Eleftherohorinou 2009 pathway analysis
PLoS ONE study analyzing GWAS data for three inflammatory diseases (Crohn's disease, RA, type 1 diabetes) using canonical pathway enrichment; identified multiple NF-kB pathway variants including those at the TNFAIP3/6q23 locus as cross-disease signals reinforced that the 6q23 region's NF-kB regulatory machinery influences risk across inflammatory conditions, not just RA, consistent with the pan-autoimmune nature of A20 biology.